Symbol="FOLD"
AssetType="Common Stock"
Name="Amicus Therapeutics Inc"
Description="Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing and delivering drugs for people living with rare metabolic diseases. The company is headquartered in Philadelphia, Pennsylvania."
CIK="1178879"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="1 CEDAR BROOK DRIVE, CRANBURY, NJ, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="3894423000"
EBITDA="-166712000"
PERatio="None"
PEGRatio="-0.18"
BookValue="0.362"
DividendPerShare="0"
DividendYield="0"
EPS="-0.68"
RevenuePerShareTTM="1.162"
ProfitMargin="-0.606"
OperatingMarginTTM="-0.51"
ReturnOnAssetsTTM="-0.141"
ReturnOnEquityTTM="-1.197"
RevenueTTM="336788000"
GrossProfitTTM="290634000"
DilutedEPSTTM="-0.68"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.096"
AnalystTargetPrice="16"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="10.51"
PriceToBookRatio="24.77"
EVToRevenue="10.46"
EVToEBITDA="-15.91"
Beta="0.839"
num_52WeekHigh="14.1"
num_52WeekLow="9.1"
num_50DayMovingAverage="12.8"
num_200DayMovingAverage="12.06"
SharesOutstanding="284576000"
DividendDate="None"
ExDividendDate="None"
symbol="FOLD"
open="13.69"
high="13.86"
low="13.21"
price="13.28"
volume="2175678.00"
latest_trading_day="2023-08-10"
previous_close="13.69"
change="-0.41"
change_percent="-2.9594%"
aroon_positive_momentum_days="48"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="48"
Volume_recent_avg="2536069"
Change_recent_avg="0.02"
Delta_recent_avg="0.41"
Variance_recent_avg="0.21"
Change_ratio_recent_avg="0.12"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="48"
Aroon_momentum_negative="52"
image_negative_thumbnail_id_1="122"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0054.jpeg"
image_negative_thumbnail_id_2="1157"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0191.jpeg"
image_neutral_thumbnail_id_1="596"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0003.jpeg"
image_neutral_thumbnail_id_2="568"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0031.jpeg"
image_positive_thumbnail_id_1="602"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0106.jpeg"
image_positive_thumbnail_id_2="686"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0022.jpeg"
image_professor_thumbnail_id_1="1203"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0037.jpeg"
image_professor_thumbnail_id_2="1196"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0030.jpeg"
